(VIANEWS) – Medigus Ltd. (MDGS), TriplePoint Venture Growth BDC Corp. (TPVG), Donegal Group (DGICA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Medigus Ltd. (MDGS) | 16.97% | 2023-04-28 07:48:07 |
| TriplePoint Venture Growth BDC Corp. (TPVG) | 14.91% | 2023-05-05 17:12:08 |
| Donegal Group (DGICA) | 4.68% | 2023-05-07 21:07:13 |
| ADTRAN (ADTN) | 4.09% | 2023-05-06 09:13:10 |
| Gilead Sciences (GILD) | 3.76% | 2023-05-11 14:55:29 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Medigus Ltd. (MDGS) – Dividend Yield: 16.97%
Medigus Ltd.’s last close was $4.80, 73.11% under its 52-week high of $17.85. Intraday change was -1.23%.
Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools with direct visualization technology in the United States, the United Kingdom, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; develops and commercializes online and offline event planning software, as well as ticketing solutions; and operates online stores for the sale of various consumer products on the Amazon online marketplace. The company was incorporated in 1999 and is headquartered in Omer, Israel.
Earnings Per Share
As for profitability, Medigus Ltd. has a trailing twelve months EPS of $-48.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.11%.
Volume
Today’s last reported volume for Medigus Ltd. is 11756 which is 49.01% below its average volume of 23058.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 18, 2022, the estimated forward annual dividend rate is 0.85 and the estimated forward annual dividend yield is 16.97%.
More news about Medigus Ltd..
2. TriplePoint Venture Growth BDC Corp. (TPVG) – Dividend Yield: 14.91%
TriplePoint Venture Growth BDC Corp.’s last close was $9.81, 39.41% below its 52-week high of $16.19. Intraday change was 0.31%.
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Earnings Per Share
As for profitability, TriplePoint Venture Growth BDC Corp. has a trailing twelve months EPS of $-0.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.7%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 19.5% and a drop 9.8% for the next.
More news about TriplePoint Venture Growth BDC Corp..
3. Donegal Group (DGICA) – Dividend Yield: 4.68%
Donegal Group’s last close was $14.48, 15.47% under its 52-week high of $17.13. Intraday change was 1.4%.
Donegal Group Inc., an insurance holding company, provides personal and commercial lines of property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. It operates through four segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The company offers private passenger automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents, as well as protection against loss from damage to automobiles. It also offers homeowners policies, which provide coverage for damage to residences and their contents from a range of perils, including fire, lightning, windstorm, and theft; and liability of the insured arising from injury to other persons or their property. In addition, the company offers commercial automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents and protection against loss from damage to automobiles owned by the insured; commercial multi-peril policies that provide protection to businesses against various perils, primarily combining liability and physical damage coverages; and workers' compensation policies, which provide benefits to employees for injuries sustained during employment. The company markets its insurance products through a network of approximately 2,400 independent insurance agencies. Donegal Group Inc. was founded in 1986 and is headquartered in Marietta, Pennsylvania.
Earnings Per Share
As for profitability, Donegal Group has a trailing twelve months EPS of $-0.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.95%.
More news about Donegal Group.
4. ADTRAN (ADTN) – Dividend Yield: 4.09%
ADTRAN’s last close was $8.75, 65.65% below its 52-week high of $25.47. Intraday change was 0.46%.
ADTRAN, Inc. provides networking and communications platforms, software, and services in the United States, Germany, the United Kingdom, Mexico, and internationally. It operates through two segments, Network Solutions, and Services & Support. The company offers fiber access and fiber to the node platforms; transceivers, cables, and other miscellaneous materials; passive optical network optical line terminals; fiber to the distribution point Gfast distribution point units; cabinet and outside plant enclosures and services; packet optical transports; fixed wireless access platforms; and network management and subscriber services, and control and orchestration software. It also provides broadband customer premises solutions, ethernet switches and routers, residential gateways, cloud-based software-as-a-service management platforms, virtual wireless local area networks, Internet of Things gateways, pre-sale and post-sale technical support, and multi-gigabit mesh Wi-Fi gateways. In addition, the company offers time division multiplexed and asynchronous transfer mode-based aggregation systems and customer devices; and high-bit-rate and asymmetric digital subscriber line, and other technologies. Further, it provides other access and aggregation, subscriber and experience, and traditional and other products, software, and services. Additionally, the company engages in the provision of planning, engineering, program management, maintenance, installation, and commissioning services to implement customer network solutions; and customer devices solutions into consumer, small business, and enterprise locations. It serves telephone or cable television network operators, and managed service providers. ADTRAN, Inc. was incorporated in 1985 and is headquartered in Huntsville, Alabama.
Earnings Per Share
As for profitability, ADTRAN has a trailing twelve months EPS of $-0.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.07%.
Yearly Top and Bottom Value
ADTRAN’s stock is valued at $8.75 at 03:15 EST, way below its 52-week high of $25.47 and above its 52-week low of $8.59.
Volume
Today’s last reported volume for ADTRAN is 967749 which is 22.82% above its average volume of 787911.
Moving Average
ADTRAN’s worth is way below its 50-day moving average of $13.49 and way under its 200-day moving average of $18.67.
More news about ADTRAN.
5. Gilead Sciences (GILD) – Dividend Yield: 3.76%
Gilead Sciences’s last close was $78.70, 12.3% below its 52-week high of $89.74. Intraday change was 0.65%.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Earnings Per Share
As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.38.
PE Ratio
Gilead Sciences has a trailing twelve months price to earnings ratio of 17.95. Meaning, the purchaser of the share is investing $17.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.11%.
More news about Gilead Sciences.
